Intel®, Cancer Research UK and Imperial College London Celebrate Supercomputing Successes in the UK

IntelToday Cancer Research UK and Imperial College London outlined the fundamental importance of High Performance Computing to their future science and research strategies. The two organisations described how Intel® High Performance Computing (HPC) solutions are enabling them to drive forward their research, which will lead to future scientific breakthroughs.

Imperial College London currently spends over £1,000 000 on its HPC programme. "HPC allows us to simulate events that would be impossible or very difficult to measure experimentally," stated Simon Burbidge, High Performance Computing Co-ordination Manager at Imperial College London. "For example, it is very difficult to reach the kind of temperatures such as those within the sun or plasmas in the real world, but by using HPC we can perform simulations to predict the results and thus tune the experiments. Another area of research at Imperial College London is using HPC to model blood flows in human arteries, to drive insights into the conditions leading to heart and circulatory disease. It is also helping us to do better research at lower cost, for example where simulations can replace some of the wind tunnel tests used in automobile design."

Peter McCallum, Head of IT & Scientific Computing at Cancer Research UK's Cambridge Research Institute described the benefits that HPC has brought to his organisation, "Through HPC we can effectively sequence a human’s whole DNA. Medical units in hospitals may soon need HPC access to enable them to track disease. We believe that in the future there will be local access to HPC with a local scientific computing team in all biological science organisations. What happened in physics and chemistry twenty years ago is now happening in biology."

Sean McGuire, Director Strategic Government Programs HPC EMEA at Intel stated, "HPC is an added direction for Intel. Through the Intel® Many Integrated Core (MIC) architecture we can achieve more compute power than would have been possible previously. It is an architecture that is designed for highly parallel workloads. We believe that it is an indication of where computing is going."

Robert Maskell, Head of HPC for Intel in the UK added, "Analysts have been telling us for a while that HPC is now mainstream, I think it is even further along the curve than that. It is pervasive. It is difficult to think of any manmade object which has not been created without being touched by HPC during the design process. HPC has become one of the fundamental building blocks for science. Researchers are being deluged by floods of data. The question they are asking is how can they cost effectively process and securely store that data. We believe Intel's Xeon range of processors deliver the energy-efficient performance that will allow researchers to draw ever quicker results and conclusions from their science."

Intel Corporation announced plans earlier this year to deliver new products based on the Intel® Many Integrated Core (MIC) architecture that will create platforms running at trillions of calculations per second, while also retaining the benefits of standard Intel processors. Targeting high-performance computing segments such as exploration, scientific research and financial or climate simulation, the first product, codenamed "Knights Corner", will be made on Intel's 22-nanometer manufacturing (nm) process - using transistor structures as small as 22 billionths of a meter - and will use Moore's Law to scale to more than 50 Intel processing cores on a single chip. While the vast majority of workloads will still run best on award-winning Intel® Xeon® processors, Intel® MIC architecture will help accelerate select highly parallel applications.

Industry design and development kits codenamed "Knights Ferry" are currently shipping to select developers, and beginning in the second half of 2010, Intel will expand the program to deliver an extensive range of developer tools for Intel MIC architecture.

Related news articles:

About Intel
Intel (NASDAQ: INTC), the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Additional information about Intel is available at www.intel.com/pressroom and blogs.intel.com.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...